mercaptoethanol has been researched along with Breast Cancer in 8 studies
Mercaptoethanol: A water-soluble thiol derived from hydrogen sulfide and ethanol. It is used as a reducing agent for disulfide bonds and to protect sulfhydryl groups from oxidation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The study aimed to assess the effect of PDT, where the combination of cyanine with 2-methoxyestradiol (2-Me) was used on mammary and ovary adenocarcinoma human cell lines." | 8.12 | The photodynamic reaction with IR-775 cyanine combined with 2-methoxyestradiol in ovarian (SKOV-3) and human breast adenocarcinoma (MDA MB-231) cell lines. ( Choromanska, A; Kulbacka, J; Saczko, J; Waszkiewicz, M, 2022) |
| "In an ongoing phase II trial conducted in advanced breast cancer, we tested a therapy schedule consisting of continuous, 24-h infusion of 5 g/m2 ifosfamide (IFO) in 3 1 dextrose saline with mesna (MSN), repeated every 3 weeks until disease progression." | 7.68 | Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer. ( Beauduin, M; Closon, MT; Focan, C; Majois, F; Michel, J; Paridaens, R; Piccart, M; Salamon, E; Tueni, E; Vindevoghel, A, 1990) |
| "Twenty-six cycles of high-dose ifosfamide + mesna (HD-IFO + M) were applied to seven female patients with advanced breast cancer refractory to prior treatment, using three different durations of continuous infusion (4, 24, and 48 h) every 3 weeks." | 7.67 | Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer. ( Brade, WP; Dittrich, C; Herold, C; Keller, A; Mader, R; Moser, K; Schlappack, O; Steger, GG, 1988) |
| "Thirty-two patients with metastatic breast cancer had previously been treated with chemotherapy (including anthracyclines)." | 5.28 | High-dose ifosfamide and mesna in advanced breast cancer. A phase II study. ( Milla, A; Sanchiz, F, 1990) |
| "The study aimed to assess the effect of PDT, where the combination of cyanine with 2-methoxyestradiol (2-Me) was used on mammary and ovary adenocarcinoma human cell lines." | 4.12 | The photodynamic reaction with IR-775 cyanine combined with 2-methoxyestradiol in ovarian (SKOV-3) and human breast adenocarcinoma (MDA MB-231) cell lines. ( Choromanska, A; Kulbacka, J; Saczko, J; Waszkiewicz, M, 2022) |
| "In an ongoing phase II trial conducted in advanced breast cancer, we tested a therapy schedule consisting of continuous, 24-h infusion of 5 g/m2 ifosfamide (IFO) in 3 1 dextrose saline with mesna (MSN), repeated every 3 weeks until disease progression." | 3.68 | Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer. ( Beauduin, M; Closon, MT; Focan, C; Majois, F; Michel, J; Paridaens, R; Piccart, M; Salamon, E; Tueni, E; Vindevoghel, A, 1990) |
| "Twenty-six cycles of high-dose ifosfamide + mesna (HD-IFO + M) were applied to seven female patients with advanced breast cancer refractory to prior treatment, using three different durations of continuous infusion (4, 24, and 48 h) every 3 weeks." | 3.67 | Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer. ( Brade, WP; Dittrich, C; Herold, C; Keller, A; Mader, R; Moser, K; Schlappack, O; Steger, GG, 1988) |
| "Thirty-two patients with metastatic breast cancer had previously been treated with chemotherapy (including anthracyclines)." | 1.28 | High-dose ifosfamide and mesna in advanced breast cancer. A phase II study. ( Milla, A; Sanchiz, F, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Waszkiewicz, M | 1 |
| Choromanska, A | 1 |
| Kulbacka, J | 1 |
| Saczko, J | 1 |
| Fourie, C | 1 |
| du Plessis, M | 1 |
| Mills, J | 1 |
| Engelbrecht, AM | 1 |
| Gong, G | 1 |
| Pan, Q | 1 |
| Wang, K | 1 |
| Wu, R | 1 |
| Sun, Y | 1 |
| Lu, Y | 1 |
| Yan, L | 1 |
| Yee, JA | 1 |
| Boylan, LM | 1 |
| Spallholz, JE | 1 |
| Paridaens, R | 1 |
| Focan, C | 1 |
| Michel, J | 1 |
| Piccart, M | 1 |
| Salamon, E | 1 |
| Beauduin, M | 1 |
| Closon, MT | 1 |
| Tueni, E | 1 |
| Vindevoghel, A | 1 |
| Majois, F | 1 |
| Sanchiz, F | 1 |
| Milla, A | 1 |
| Steger, GG | 1 |
| Dittrich, C | 1 |
| Schlappack, O | 1 |
| Mader, R | 1 |
| Herold, C | 1 |
| Brade, WP | 1 |
| Keller, A | 1 |
| Moser, K | 1 |
| Braunsberg, H | 1 |
| Killen, E | 1 |
| Richardson, SG | 1 |
8 other studies available for mercaptoethanol and Breast Cancer
| Article | Year |
|---|---|
The photodynamic reaction with IR-775 cyanine combined with 2-methoxyestradiol in ovarian (SKOV-3) and human breast adenocarcinoma (MDA MB-231) cell lines.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Female; Humans; M | 2022 |
The effect of HIF-1α inhibition in breast cancer cells prior to doxorubicin treatment under conditions of normoxia and hypoxia.
Topics: Breast Neoplasms; Cell Hypoxia; Cell Line, Tumor; Doxorubicin; Female; Humans; Hypoxia; Hypoxia-Indu | 2022 |
Curcumin-incorporated albumin nanoparticles and its tumor image.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Curcumin; Drug Carriers; Humans; Hydro | 2015 |
Effect of selenium compounds and thiols on human mammary tumor cells.
Topics: Aged; Antimetabolites; Breast Neoplasms; Buthionine Sulfoximine; Cell Survival; Cysteine; Female; Gl | 1991 |
Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Ifosfamide; | 1990 |
High-dose ifosfamide and mesna in advanced breast cancer. A phase II study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Evaluation; Fema | 1990 |
Toxicity and response to high-dose ifosfamide + mesna as salvage therapy for advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Ifosf | 1988 |
The effect of thiols on oestradiol binding by components of human malignant breast tumours.
Topics: Binding Sites; Breast Neoplasms; Cysteine; Dithiothreitol; Estradiol; Female; Humans; Mercaptoethano | 1972 |